Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quality Assurance01:19

Quality Assurance

4.0K
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
4.0K
Integrated Healthcare System01:20

Integrated Healthcare System

2.6K
An integrated healthcare system (IHS) is a set of organizations that provides for or arranges to provide coordinated and continuous service to a defined population. The IHS takes responsibility for that particular population's health status and outcome, both clinically and fiscally. An integrated healthcare system is a well-organized, well-coordinated, and collaborative network. The integrated delivery system is a network that connects different healthcare providers to deliver organized,...
2.6K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.9K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.9K
Modeling and Similitude01:12

Modeling and Similitude

790
Scaled modeling is a fundamental technique in engineering, enabling the study of large and complex systems by creating smaller, manageable replicas that recreate critical characteristics of the original. In hydrology and civil infrastructure, for example, scaled models of dams help analyze water flow, turbulence, and pressure. This method allows for accurate predictions of real-world behavior within a controlled environment, significantly reducing the cost and time involved in full-scale...
790
Nursing Clinical Information System01:27

Nursing Clinical Information System

1.5K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.5K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

957
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
957

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of Virtual Twin PBPK Models in Individuals with Obesity via CYP3A4 Phenotyping Using Endogenous Biomarker Data.

Clinical pharmacology and therapeutics·2026
Same author

Proteomic profiling of metabolizing enzymes and transporters in 2 layers of Caucasian human skin.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Clustering of multimorbidity in stroke and transient ischaemic attack survivors: a population-based study.

BMC medicine·2026
Same author

A Review of Virtual Twins in Physiologically-Based Pharmacokinetic Modeling and Simulation.

Clinical pharmacology and therapeutics·2026
Same author

Proteomics-Informed Physiologically Based Pharmacokinetic Modeling for Aldehyde Oxidase Substrates in Colorectal Cancer Liver Metastasis.

Molecular pharmaceutics·2026
Same author

Voice recognition as an innovative method to identify and monitor heart failure - a review.

Heart failure reviews·2026

Related Experiment Video

Updated: Apr 19, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.4K

The simcyp population based simulator: architecture, implementation, and quality assurance.

Masoud Jamei1, Steve Marciniak1, Duncan Edwards1

  • 1Simcyp Limited (a Certara Company), Blades Enterprise Centre, John Street, Sheffield, S2 4SU UK.

In Silico Pharmacology
|December 16, 2014
PubMed
Summary
This summary is machine-generated.

The Simcyp Simulator platform now handles complex physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) models for diverse drugs. Enhancements improve drug development from discovery to regulatory submission.

Keywords:
ADMEModel based drug developmentPharmacodynamicsPharmacokineticsPhysiologically-based pharmacokineticSimcyp

More Related Videos

Creating a Structurally Realistic Finite Element Geometric Model of a Cardiomyocyte to Study the Role of Cellular Architecture in Cardiomyocyte Systems Biology
08:54

Creating a Structurally Realistic Finite Element Geometric Model of a Cardiomyocyte to Study the Role of Cellular Architecture in Cardiomyocyte Systems Biology

Published on: April 18, 2018

10.2K
Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction
16:23

Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction

Published on: February 26, 2014

15.0K

Related Experiment Videos

Last Updated: Apr 19, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.4K
Creating a Structurally Realistic Finite Element Geometric Model of a Cardiomyocyte to Study the Role of Cellular Architecture in Cardiomyocyte Systems Biology
08:54

Creating a Structurally Realistic Finite Element Geometric Model of a Cardiomyocyte to Study the Role of Cellular Architecture in Cardiomyocyte Systems Biology

Published on: April 18, 2018

10.2K
Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction
16:23

Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction

Published on: February 26, 2014

15.0K

Area of Science:

  • Pharmacokinetics and Pharmacodynamics (PBPK/PD) modeling
  • Drug Development and Discovery
  • Computational Biology and Pharmacology

Background:

  • Developing advanced platforms for complex physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) models presents significant challenges.
  • The Simcyp Population Based Simulator has become a widely adopted tool in major pharmaceutical companies.
  • The platform has evolved into a comprehensive Model Based Drug Development (MBDD) solution.

Purpose of the Study:

  • To provide an update on recent architectural and implementation developments within the Simcyp Simulator.
  • To detail advancements in handling complex PBPK/PD models for both small molecules and biologics.
  • To highlight improvements in data management and integration for regulatory compliance.

Main Methods:

  • Describing the interconnection between peripheral modules within the simulator architecture.
  • Explaining the dynamic model building process and data handling for compounds and populations.
  • Integrating the Simcyp Data Management (SDM) system for enhanced quality control and tracking.

Main Results:

  • The updated Simcyp Simulator offers a more robust platform for complex PBPK/PD modeling.
  • Enhanced data management through SDM facilitates seamless integration, tracking, and quality standards.
  • Improvements support internal approval, validation, and auto-testing of new models and algorithms.

Conclusions:

  • The Simcyp Simulator is a sophisticated MBDD platform supporting the entire drug development lifecycle.
  • Recent developments enhance its capability to manage complex models and ensure data quality for regulatory submissions.
  • The platform's evolution addresses the need for user-friendly, comprehensive solutions in pharmaceutical R&D.